D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
MRNS holding history
Marinus Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRNS overviewAll 13F holders of MRNSFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −178,801−100.0% | Sold out | Holders |
| Q3 2024 | 178,801 | $314.7K | <0.1% | +178,801 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −11,400−100.0% | Sold out | Holders |
| Q3 2023 | 11,400 | $91.8K | <0.1% | −343,348−96.8% | Reduced | Holders |
| Q2 2023 | 354,748 | $3.85M | <0.1% | +266,521+302.1% | Added | Holders |
| Q1 2023 | 88,227 | $608.8K | <0.1% | +88,227 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −17,203−100.0% | Sold out | Holders |
| Q1 2021 | 17,203 | $266.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.